534-42-9
Chemical Structure
Maltobionic acid
Synonym(s): 4-O-α-D-Glucopyranosyl-D-gluconic acid
- CAS No.: 534-42-9
- Formula:C12H22O12
- Molecular Weight:358.30
IUPAC Name: 3-(3-amino-4-bromophenyl)propanoic acid
InChIKey: JYTUSYBCFIZPBE-QOKIMYEXSA-N
SMILES: OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C(O)=O
Biological Activity: Maltobionic acid (4-O-α-D-Glucopyranosyl-D-gluconic acid) is an orally active oligosaccharide and iron chelator with antibacterial activity. Maltobionic acid inhibits the expression of NFATc1, suppresses osteoclast differentiation, inhibits bone resorption, and increases serum calcitonin levels. Maltobionic acid protects mammalian cells from hydrogen peroxide (H2O2)-induced oxidative damage; resists fermentation by the gut microbiota; and exhibits anti-digestive and anti-fermentative properties. Maltobionic acid can be used in research related to osteoporosis, bacterial infections, and constipation[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Maltobionic acid | 90.0% | Maltobionic acid (4-O-α-D-Glucopyranosyl-D-gluconic acid) is an orally active oligosaccharide and iron chelator with antibacterial activity. Maltobionic acid inhibits the expression of NFATc1, suppresses osteoclast differentiation, inhibits bone resorption, and increases serum calcitonin levels. Maltobionic acid protects mammalian cells from hydrogen peroxide (H2O2)-induced oxidative damage; resists fermentation by the gut microbiota; and exhibits anti-digestive and anti-fermentative properties. Maltobionic acid can be used in research related to osteoporosis, bacterial infections, and constipation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
[1]. Nishio A, et al. Maltobionic acid protects against ovariectomy‐induced osteoporosis by suppressing bone resorption. JSFA Reports. 2024 Nov;4(11):384-93.
- [2]. de Souza RC, et al. Purification, bioactivity and application of maltobionic acid in active films. 3 Biotech. 2024;14(1):32. [Content Brief]
- [3]. Tanabe K, et al. Metabolic fate of newly developed nondigestible oligosaccharide, maltobionic acid, in rats and humans. Food Sci Nutr. 2020;8(7):3610-3616. Published 2020 May 20. [Content Brief]
- [4]. Fukami K, et al. In Vitro Utilization Characteristics of Maltobionic Acid and Its Effects on Bowel Movements in Healthy Subjects. J Appl Glycosci (1999). 2020;67(1):1-9. Published 2020 Feb 20. [Content Brief]
Keywords
